8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Honey as an immunomodulator during sepsis in animal model

      abstract
      1 , , 1 , 2 , 1 , 3 , 4
      Critical Care
      BioMed Central
      Sepsis 2009
      11–14 November 2009

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction Malaysian honey (Gelam) has antibacterial activity and it also has a high antioxidant capacity and free radical scavenger activities. Honey extracts showed potent activity against TNFα in L929 cell and NO in RAW 264.7 macrophage as well as inhibitory effects on the prostaglandin E2 and nitric oxide (NO) in inflammatory tissues of rat. Sepsis is mediated in part by bacterial endotoxin, which stimulates macrophages/monocytes to sequentially release early (for example, TNF, IL-1) cytokines and inducible enzymes such as inducible nitric oxide (iNOS) synthase and heme oxygenase 1 (HO-1) and late such as high-mobility group box 1 (HMGB1). Objective To investigate the role of honey as an immunomodulator in sepsis induced by LPS in rats. Methods Four groups (n = 6) of rats were used. The treatment group received honey with LPS, the positive control group were given LPS (5 mg/kg), the negative control group were given saline only, while the fourth group were only given honey; all doses were 1 ml by intravenous route. Blood samples were collected 4 hours later and all rats were sacrificed after 24 hours. TNFα, IL-1β, IL-6, IL-10, NO, HO-1 and HMGB1 were quantified using ELISA. The effect of honey on coagulation (PT and APPT) in whole blood ex vivo from healthy volunteers (n = 10) was measured. Results After 4 hours of treatment, the cytokines, NO and HO-1 were measured in all groups. Honey showed evidence of immuno-modulatory effects with reduced cytokines (TNFα (P < 0.001), IL-1β (P < 0.001), IL-10 (P < 0.001)) and NO (P < 0.037) in the treatment group, while the change in IL-6 was not significant between all groups, HO-1 (P < 0.001) was increased in the treatment group, but only slightly increased in the honey group. After 24 hours of treatment, HMGB1 (P < 0.025) and IL-1β (P < 0.001) were reduced in the treatment group as well. HO-1 (P < 0.013) continuously increased in all groups. Curiously, honey alone induced TNFα (P < 0.001) and IL-1β (P < 0.03) at 4 hours, and HO-1 (P < 0.028) at 24 hours compared with saline. Honey prolonged the time of PT and APPT in a dose-dependent manner. Conclusion Honey behaves as immunomodulator by acting in two ways, by inducing HO-1, TNFα, and IL-1β and at the same time inhibiting cytokines, NO and HMGB1 that is induced by LPS. However, the exact mechanism remain unclear, but our suggestion is that since honey induces HO-1, TNFα and IL-1β this may cause changes or inhibition in the signaling of cytokines and NF-κB. Honey could therefore be used as a pharmacological tool in sepsis in the future.

          Related collections

          Author and article information

          Conference
          Crit Care
          Critical Care
          BioMed Central
          1364-8535
          1466-609X
          2009
          11 November 2009
          : 13
          : Suppl 4
          : P40
          Affiliations
          [1 ]Department of Anesthesiology, University of Malaya, Kuala Lumpur, Malaysia
          [2 ]Department of Pharmacology, University of Malaya, Kuala Lumpur, Malaysia
          [3 ]Department of Medical Microbiology, University of Malaya, Kuala Lumpur, Malaysia
          [4 ]Department of Molecular Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
          Article
          cc8096
          10.1186/cc8096
          2776213
          8a1495c9-e830-4a47-a43c-e16c2b3442c3
          Copyright © 2009 BioMed Central Ltd.
          Sepsis 2009
          Amsterdam, The Netherlands
          11–14 November 2009
          History
          Categories
          Poster Presentation

          Emergency medicine & Trauma
          Emergency medicine & Trauma

          Comments

          Comment on this article